PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
BIT:PHN - Borsa Italiana Milan - IT0005274094 - Common Stock - Currency: EUR
We assign a fundamental rating of 7 out of 10 to PHN. PHN was compared to 12 industry peers in the Personal Care Products industry. PHN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PHN has a decent growth rate and is not valued too expensively. This makes PHN very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year PHN was profitable.
PHN had a positive operating cash flow in the past year.
In the past 5 years PHN has always been profitable.
In the past 5 years PHN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of PHN (17.55%) is better than 100.00% of its industry peers.
The Return On Equity of PHN (35.81%) is better than 83.33% of its industry peers.
With an excellent Return On Invested Capital value of 23.37%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PHN had an Average Return On Invested Capital over the past 3 years of 18.48%. This is significantly above the industry average of 11.84%.
The last Return On Invested Capital (23.37%) for PHN is above the 3 year average (18.48%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.55% | ||
| ROE | 35.81% | ||
| ROIC | 23.37% |
ROA(3y)15.25%
ROA(5y)18.05%
ROE(3y)27.89%
ROE(5y)30.2%
ROIC(3y)18.48%
ROIC(5y)19.46%
1.3 Margins
PHN has a Profit Margin of 12.90%. This is in the better half of the industry: PHN outperforms 75.00% of its industry peers.
PHN's Profit Margin has declined in the last couple of years.
The Operating Margin of PHN (21.91%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of PHN has declined.
PHN's Gross Margin of 95.90% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
PHN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.91% | ||
| PM (TTM) | 12.9% | ||
| GM | 95.9% |
OM growth 3Y-1.61%
OM growth 5Y-1.8%
PM growth 3Y-19.91%
PM growth 5Y-6.93%
GM growth 3Y0.82%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PHN is creating value.
Compared to 1 year ago, PHN has less shares outstanding
PHN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for PHN is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.69 indicates that PHN is not in any danger for bankruptcy at the moment.
PHN's Altman-Z score of 8.69 is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
PHN has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.
PHN has a better Debt to FCF ratio (1.84) than 66.67% of its industry peers.
PHN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
PHN has a Debt to Equity ratio of 0.42. This is comparable to the rest of the industry: PHN outperforms 58.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.84 | ||
| Altman-Z | 8.69 |
ROIC/WACC3.02
WACC7.74%
2.3 Liquidity
PHN has a Current Ratio of 2.11. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PHN (2.11) is better than 91.67% of its industry peers.
A Quick Ratio of 1.84 indicates that PHN should not have too much problems paying its short term obligations.
The Quick ratio of PHN (1.84) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.84 |
3. Growth
3.1 Past
PHN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.74%.
PHN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.59% yearly.
Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 14.28% in the last year.
The Revenue has been growing by 16.51% on average over the past years. This is quite good.
EPS 1Y (TTM)-14.74%
EPS 3Y-2.81%
EPS 5Y8.59%
EPS Q2Q%69.23%
Revenue 1Y (TTM)14.28%
Revenue growth 3Y21.08%
Revenue growth 5Y16.51%
Sales Q2Q%25.66%
3.2 Future
PHN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.67% yearly.
Based on estimates for the next years, PHN will show a quite strong growth in Revenue. The Revenue will grow by 13.89% on average per year.
EPS Next Y43.02%
EPS Next 2Y30.62%
EPS Next 3Y25.67%
EPS Next 5YN/A
Revenue Next Year15.93%
Revenue Next 2Y14.69%
Revenue Next 3Y13.89%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 38.95, which means the current valuation is very expensive for PHN.
Based on the Price/Earnings ratio, PHN is valued expensively inside the industry as 91.67% of the companies are valued cheaper.
The average S&P500 Price/Earnings ratio is at 28.47. PHN is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 22.83, PHN is valued on the expensive side.
PHN's Price/Forward Earnings is on the same level as the industry average.
PHN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.95 | ||
| Fwd PE | 22.83 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHN is on the same level as its industry peers.
PHN's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PHN is more expensive than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.14 | ||
| EV/EBITDA | 13.39 |
4.3 Compensation for Growth
PHN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of PHN may justify a higher PE ratio.
PHN's earnings are expected to grow with 25.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.91
PEG (5Y)4.53
EPS Next 2Y30.62%
EPS Next 3Y25.67%
5. Dividend
5.1 Amount
PHN has a Yearly Dividend Yield of 1.67%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.13, PHN has a dividend in line with its industry peers.
PHN's Dividend Yield is slightly below the S&P500 average, which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.67% |
5.2 History
The dividend of PHN is nicely growing with an annual growth rate of 19.41%!
Dividend Growth(5Y)19.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
41.64% of the earnings are spent on dividend by PHN. This is a bit on the high side, but may be sustainable.
The dividend of PHN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.64%
EPS Next 2Y30.62%
EPS Next 3Y25.67%
PHARMANUTRA SPA
BIT:PHN (2/5/2025, 9:13:04 AM)
51.8
-0.1 (-0.19%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners14.66%
Inst Owner ChangeN/A
Ins Owners65%
Ins Owner ChangeN/A
Market Cap501.42M
Analysts82.86
Price Target86.02 (66.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.67% |
Yearly Dividend0.8
Dividend Growth(5Y)19.41%
DP41.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.21%
EPS NY rev (3m)5.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.42%
Revenue NY rev (3m)1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.95 | ||
| Fwd PE | 22.83 | ||
| P/S | 3.3 | ||
| P/FCF | 34.14 | ||
| P/OCF | 25.41 | ||
| P/B | 9.15 | ||
| P/tB | 15.89 | ||
| EV/EBITDA | 13.39 |
EPS(TTM)1.33
EY2.57%
EPS(NY)2.27
Fwd EY4.38%
FCF(TTM)1.52
FCFY2.93%
OCF(TTM)2.04
OCFY3.94%
SpS15.72
BVpS5.66
TBVpS3.26
PEG (NY)0.91
PEG (5Y)4.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.55% | ||
| ROE | 35.81% | ||
| ROCE | 39.93% | ||
| ROIC | 23.37% | ||
| ROICexc | 31.41% | ||
| ROICexgc | 49.61% | ||
| OM | 21.91% | ||
| PM (TTM) | 12.9% | ||
| GM | 95.9% | ||
| FCFM | 9.65% |
ROA(3y)15.25%
ROA(5y)18.05%
ROE(3y)27.89%
ROE(5y)30.2%
ROIC(3y)18.48%
ROIC(5y)19.46%
ROICexc(3y)35.34%
ROICexc(5y)39.3%
ROICexgc(3y)54.37%
ROICexgc(5y)58.28%
ROCE(3y)31.09%
ROCE(5y)32.96%
ROICexcg growth 3Y-11.78%
ROICexcg growth 5Y-13.93%
ROICexc growth 3Y-16.83%
ROICexc growth 5Y-14.78%
OM growth 3Y-1.61%
OM growth 5Y-1.8%
PM growth 3Y-19.91%
PM growth 5Y-6.93%
GM growth 3Y0.82%
GM growth 5Y0.6%
F-Score6
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.84 | ||
| Debt/EBITDA | 0.61 | ||
| Cap/Depr | 126.93% | ||
| Cap/Sales | 3.32% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 52.88% | ||
| Profit Quality | 74.84% | ||
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.84 | ||
| Altman-Z | 8.69 |
F-Score6
WACC7.74%
ROIC/WACC3.02
Cap/Depr(3y)846.71%
Cap/Depr(5y)622.37%
Cap/Sales(3y)16.18%
Cap/Sales(5y)12.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.74%
EPS 3Y-2.81%
EPS 5Y8.59%
EPS Q2Q%69.23%
EPS Next Y43.02%
EPS Next 2Y30.62%
EPS Next 3Y25.67%
EPS Next 5YN/A
Revenue 1Y (TTM)14.28%
Revenue growth 3Y21.08%
Revenue growth 5Y16.51%
Sales Q2Q%25.66%
Revenue Next Year15.93%
Revenue Next 2Y14.69%
Revenue Next 3Y13.89%
Revenue Next 5YN/A
EBIT growth 1Y-9.65%
EBIT growth 3Y19.13%
EBIT growth 5Y14.41%
EBIT Next Year49.84%
EBIT Next 3Y24.24%
EBIT Next 5Y13.46%
FCF growth 1Y53.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.44%
OCF growth 3Y0.82%
OCF growth 5Y13.45%